Results from a phase 2 clinical trial showed that treatment with an IgG-cleaving enzyme for individuals diagnosed with Guillain-Barré syndrome led to faster muscle strength recovery and mobility ...

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus (RSV) vaccine. Two people in … ...

Johnson & Johnson’s beleaguered Covid-19 vaccine may be associated with a small increased risk of Guillain-Barré syndrome, a rare but potentially serious neurological condition, federal ...

Sept. 20 (UPI) --Sufjan Stevens is going public with his struggle with Guillain-Barré syndrome. The 48-year-old singer-songwriter said in a post Wednesday that he is recovering and relearning to ...

A haywire immune system, attacking healthy nerves, causes the disorder. U.S. health authorities added a warning to the label of J&J’s Covid-19 vaccine after finding 100 reports.

Sufjan Stevens is battling Guillain-Barre syndrome. He said on Instagram that he is currently in physical therapy relearning how to walk.

Guillain-Barré syndrome (GBS) is a rare nerve disorder that can occur after an infection. It develops due to an overreaction of the immune system. There are several types of GBS. Guillain-Barré ...

Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting about 1 in 100,000 people, according to the U.S. Centers for Disease Control and Prevention. Fox News Media Fox Business ...

"Clarifying the cause of Guillain-Barré Syndrome." ScienceDaily. www.sciencedaily.com / releases / 2024 / 01 / 240119122700.htm (accessed June 2, 2025). Explore More ...